Senior Clinical Trial Manager (Sr. CTM)
Required skills
- Clinical Trial Management
- FDA
- EMA
- ICH
- GCP
- global trials
- vendor management
- CRO
- contract negotiation
- budget forecasting
Nice to have
- biological sciences
- AI-integrated discovery engine
- targeted protein degradation
Role summary
Nurix Therapeutics is seeking a Senior Clinical Trial Manager (Sr. CTM) to manage a portfolio of clinical trials or a geographic region. This role involves owning operational strategy, shaping protocol and study design, leading vendor selection and contract negotiation, and serving as an escalation point. The Sr. CTM will also manage program-level budgets, mentor junior staff, lead audit readiness, and represent Clinical Operations externally. The ideal candidate has a S./B.A. in biological sciences with 8-10+ years of relevant industry experience, deep knowledge of regulatory guidelines (FDA, EMA, ICH, GCP), and proven experience managing global trials and strategic vendor relationships. Strong executive presence and organizational skills are essential for this fast-paced, small-company environment.
Senior Clinical Trial Manager (Sr CTM)
You’ve run trials well — now run more of them, and help others do the same. You’ll manage a portfolio of trials or a full region, own vendor strategy end-to-end, and become the person other CTMs turn to when something’s stuck.
Position Description
This individual manages clinical regions and/or multiple trials simultaneously, with broad involvement in work central to Nurix’s strategic goals, and plays a key role in developing junior clinical operations staff.
The Opportunity
What You’ll Bring
Salary Range: $181,900 – $193.827 annually
The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate’s relevant experience, technical expertise, and how their background aligns with the role’s requirements.
Location: Onsite – Brisbane, CA
Fit with Nurix Culture and Values
About Nurix Therapeutics
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.
